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All tissue culture systems for propagating HBV employed so far make use of tandemly arranged HBV genomes usually
under the control of strong foreign promoters. Thus these systems are helpful for virus production but are of limited value
in the investigation of the regulation of HBV replication or of the extent to which the expression of viral genes might be
influenced by cellular signal transduction pathways. To overcome this barrier we established an HBV-producing cell line
(HepG2-4A5) by stably transfecting HepG2 cells with a replication-competent, terminally redundant HBV plasmid (pSPT1.2
1HBV) that contains each of the four major HBV-ORFs only once and exclusively under the control of their own regulatory
elements. HepG2-4A5 cells contain a single, nonrearranged, chromosomally integrated, replication-competent HBV genome.
In the cytoplasm of HepG2-4A5 cells, all typical viral mRNAs were detectable, but no other viral transcripts were found.
Furthermore, all viral gene products are synthesized in a balanced ratio, as close as possible to that found in an in vivo
infection. Dane-like particles released from HepG2-4A5 cells were indistinguishable from virions synthesized in vivo, by all
physical (electron microscopy, buoyant density) and biochemical (endogenous polymerase reaction, immunogenic behaviour)
criteria. Because of the autologous genome organization in this system, the HepG2-4A5 cell line allows studies on the
function of the HBV gene products with respect to their involvement in regulating HBV replication under conditions imitating
as closely as possible the situation in vivo. Furthermore, this cell line might be a helpful tool in screening antiviral drugs
and in studying their effect on regulating HBV replication. q 1996 Academic Press, Inc.
Hepatitis B virus (HBV) is an important human patho- To overcome this barrier, we have established a new
cell line, referred to as HepG2-4A5, that continuously pro-gen that chronically infects more than 200 million people
worldwide. Prolonged infection has been associated with duces potentially infective hepatitis B virions. To express
the viral proteins, we employed—in contrast to the cellcirrhosis and hepatocellular carcinoma (1). To investigate
HBV replication, appropriate in vitro systems imitating lines established so far—a merely terminally redundant
HBV genome (pSPT1.2 1 HBV) (Fig. 1a), which has onlythe in vivo situation as closely as possible are necessary.
The most common of the cell lines established so far, the minimal size necessary for transcription of all viral
RNAs. The terminal redundancy of the recombinant viralthe HepG2-2.2.15, contains two head-to-tail copies of the
HBV genome between the long terminal repeats of Molo- genome is necessary because HBV replicates via reverse
transcription of a 3.5-kb pregenomic RNA, resulting in aney murine leukemia virus (2). This cell line is based on
the human hepatoblastoma cell line HepG2 (3). Another 3.2-kb partially double-stranded DNA genome, which is
part of the virion (outlined in Fig. 1a). Plasmid pSPT1.21well-characterized cell line, stably producing HBV parti-
cles from a chromosomally integrated state, is the HB611 HBV contains each of the four major open reading frames
only once and exclusively under the control of their autolo-cell line (4), which was established by transfecting Huh6-
c15 cells with plasmid p3HB-neo and which carries three gous regulatory elements (Fig. 1a). Transfection of HepG2
cells with plasmid pSPT1.2xHBV resulted in the secretiontandemly arranged HBV genomes. Although these tissue
culture systems have been very helpful for in vitro pro- of HBsAg and HBeAg with a maximum around Day 4 to
5 (data not shown). To establish a stably transfected cellduction of HBV, they do not allow studies on the regula-
tion of HBV replication, since all of them harbor more than line, HepG2 cells were transfected with plasmid pSPT1.2
1 HBV carrying a neomycin-resistant gene which is con-one HBV genome and since—especially in the case of
HepG2-2.2.15 cells—HBV gene expression is forced by trolled by the herpes simplex TK promoter and cells were
selected for G418 resistance. To rule out the possibilitystrong foreign promoters. In any case, viral genes are
no longer expressed in a balanced ratio that is compara- that the transcription of the viral genes can be affected
by the TK promoter, as might be the case with HB611ble to the situation in vivo..
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FIG. 1. (a) Genomic organization of plasmid pSPT1.2xHBV, showing the HBV ORFs and the most important restriction sites along the HBV genome,
together with their nucleotide positions, starting at the unique XhoI (3215/1) site within the HBV genome. The truncated X-ORF shown on the
5*-end does not encode a functional transactivator (data not shown) and is therefore delineated in dashed lines. (b) Southern blot analysis of
chromosomal DNA prepared from HepG2-4A5 cells. Viral DNA was detected by a randomly primed 32-P-labeled whole HBV DNA probe. (c) Preparation
of intracellular episomal HBV DNA was carried out according to the method of Hirt (5) and analyzed in the same way. (d) Northern blot analysis of
Poly(A)/-RNA, extracted from HepG2-2.2.15 and HepG2-4A5 cells. Hybridization was performed either with a full-length HBV probe (HBV-probe) or
with an HBV fragment spanning parts of the S-ORF but lacking the X-ORF (HBx-minus-probe).
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cells (4 ), the HBV genome and the selective marker have size (3.8, 4.0, 6.1, and 1.7 kb). Whether these transcripts
are generated because of the head-to-tail orientation ofbeen oriented in opposite directions. Thirty-seven neomy-
cin-resistant cell clones were propagated as individual the integrated viral DNA in HepG2-2.2.15 cells or whether
they reflect viral/cellular fusion transcripts cannot be an-cell cultures and screened for HBsAg and HBeAg expres-
sion. Five cell clones were assayed to be positive for swered by these data.
To characterize viral particles secreted from HepG2-both viral antigens, strongly suggesting that they were
propagating the virus. One cell clone, the highest producer 4A5 cells, culture medium was concentrated and sub-
jected to isopycnic CsCl density gradient centrifugation.of HBsAg and HBeAg, was chosen for further analysis. To
ensure that this cell clone is really based on a single Fractions of this gradient were tested for density, the
presence of HBsAg and HBeAg, and for viral DNA (Fig.cell, a limited dilution was carried out and all subsequent
experiments were done with this monoclonal cell line, 2a). A peak of HBeAg was observed at a density of 1.32–
1.34 g/cm3 (fraction 15 and 16) and two peaks of HBsAgnamed HepG2-4A5.
To investigate the structure of the integrated HBV DNA, around a density of 1.22 g/cm3 (fraction 9) and 1.28
g/cm3 (fraction 14), respectively. Regarding their buoyantchromosomal DNA was prepared from HepG2-4A5 cells
(71st passage) and subjected to Southern blot analysis densities and their antigenic behavior, these peaks can
be considered as corresponding to HBV core particles(Fig. 1b). Digestion of chromosomal DNA with HindIII,
which does not cleave within the HBV genome, produced lacking the outer envelope, subviral filamentous and
spherical HBsAg particles, and viral particles (Dane parti-a single, high molecular weight band (lane 4) while diges-
tion with HindIII/XhoI revealed, as expected, two bands cles). The same three particle species are also found in
the blood of virus carriers in vivo. The presence of a(compare with Fig. 1a) but no further DNA fragments,
containing HBV DNA (lane 5). Therefore, the terminally defined peak within fractions 12 to 17 containing HBV
DNA, as shown by dot blot hybridization, was taken asredundant HBV DNA must have been integrated at a
single locus on the host chromosome. Digestion with a first indication that Dane particles are secreted from
HepG2-4A5 cells. This predicted correlation was con-BamHI produced the expected two bands, one with 3.2
kb (lane 2), and digestion with BglII, which cleaves at firmed by electron microscopy of pooled fractions 8 to
15, showing spherical 22-nm particles, HBsAg filamentstwo sites within the HBV genome, shows that the head-
to-tail junction within the 1.2xHBV genome is still intact. with the same diameter but variable length, and 42-nm
Dane particles (Fig. 2b). To prove directly that 42-nmBglII digest revealed the presence of a 440-bp fragment,
together with a 2.8-kb fragment which could only have particles secreted into the culture medium from HepG2-
4A5 cells are bona fide HBV virions, particles were immu-been derived from a head-to-tail orientation. Conse-
quently, HepG2-4A5 cells contain a single, nonre- noprecipitated and subjected to an endogenous polymer-
ase reaction (EPR). One of the characteristic features ofarranged, terminally redundant HBV genome in a chro-
mosomally integrated state. To show the structure of the HBV is its partially double-stranded DNA genome, which
is the basis for the endogenous polymerase reaction (6)extrachromosomal viral DNA intermediates, episomal
DNA was prepared from the cytoplasm of HepG2-4A5 showing the enzymatic activity of the HBV polymerase
inside replication-competent nucleocapsids. A labeledcells according to the method of Hirt (5). All types of viral
replication intermediates, in particular the approximately DNA band with a molecular weight of about 3.5 kb was
observed when the EPR was carried out with tissue cul-1.6-kb single-stranded L(-)-DNA, the 3.2-kb linear double-
stranded, and the 3.5-kb circular, partially double- ture supernatant of HepG2-4A5 cells. A DNA band of the
same molecular weight, but with higher intensity wasstranded DNA were detectable in HepG2-4A5 cells (Fig.
1c; lane 1). DNA bands of the same size were observed found in the case of HepG2-2.2.15 cells, which were
again used as a positive control. Taken together, it canin HepG2-2.2.15 cells, which were used as a positive
control (Fig. 1c; lane 2). The finding that the integrated be assumed that Dane-like particles released from
HepG2-4A5 cells are indistinguishable from those syn-viral DNA is still intact was confirmed by Northern blot-
ting of polyadenylated viral RNA (Fig. 1d). For HepG2- thesized in vivo, by all physical (buoyant density, mor-
phology) and biochemical (EPR, antigenicity) criteria.4A5 cells, two major RNA species were found, one at
about 3.5 kb and another very dominant transcript with Attempts to propagate HBV in vitro have so far only
resulted in permanent HBV production, if tandemly ar-an apparent size of about 2.1 kb. Less prominent HBV-
specific transcripts were detected at positions corre- ranged complete HBV genomes, usually under the control
of strong foreign promoters, have been used, in order tosponding to 2.4 and in particular 0.7 kb. Viral transcripts
of the same size and in comparable amounts are also ensure the genomic continuity after chromosomal integra-
tion and the efficient transcription of the viral RNAs. Wefound during natural HBV infection, confirming the close
imitation of the in vivo situation by the HepG2-4A5 sys- have shown here that merely a 1.2-fold HBV genome just
large enough to act as a template for the synthesis of thetem. In contrast, HepG2-2.2.15 cells (2) synthesize not
only these viral, but also atypical transcripts of different 3.5-kb pregenomic RNA and which contains the HBV ORFs
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FIG. 2. (a) Particles released from HepG2-4A5 cells were concentrated, subjected to CsCl density gradient centrifugation, and analyzed by enzyme
immunoassay for HBsAg (circles) and HBc/eAg (squares). HBsAg fractions were diluted 40-fold and HBc/eAg fractions 5-fold. The density of each
fraction was determined by refractometry. DNA from each fraction was recovered and analyzed by dot blot hybridization. (Cut-off values for the
enzyme immunoassays were 0.056 for HBsAg and 0.105 for HBc/eAg). (b) To ascertain the production of viral and subviral particles by HepG2-4A5
cells, fractions 8 to 15 were pooled and examined by electron microscopy. The micrograph shows filamentous and spherical subviral HBsAg
particles and 42-nm virus-like particles. (c) Endogenous polymerase reaction (6) after immunoprecipitation of viral particles released from HepG2-
4A5 cells and HepG2-2.2.15 cells, respectively, with an anti-HBc-antibody (DAKO).
only once and exclusively under the control of their autolo- line that contains an HBV integrate encoding each viral
message only once and exclusively under the control ofgous regulatory elements, is sufficient for in vitro produc-
tion of HBV. This organization was preserved after chro- its own regulatory elements. No atypical viral transcripts
are synthesized in HepG2-4A5 cells. Northern blot analy-mosomal integration, leading to the conclusion that
HepG2-4A5 cells contain a single, nonrearranged, termi- sis has revealed the presence of four HBV RNA species:
the 3.5-kb genomic transcripts, the 2.1- and 2.4-kb S-nally redundant HBV genome. In the tissue culture super-
natant of HepG2-4A5 cells, all types of viral and subviral gene transcripts, and traces of a 0.7-kb transcript repre-
senting the X-ORF. In HepG2-4A5 cells the 2.1-kb mes-particles were detectable, and they showed the same mor-
phology as virions synthesized in vivo. Dane-like particles sage, which initiates from the preS2 promoter region,
represents the vast majority of the viral transcripts,released from HepG2-4A5 cells harbor a partially double-
stranded DNA genome and an enzymatically active viral whereas the 2.4 kb and especially the HBx messages
are only barely detectable. A similar ratio is also foundpolymerase. Using quantitative dot blot hybridization, we
calculated that approximately 105 to 106 virions/ml tissue during natural infection. Under these conditions the pre-
dominant transcripts are also the 2.1-kb messages (8).culture supernatant were secreted from HepG2-4A5 cells
(data not shown). It has been shown by Acs and cowork- This illustrates the close imitation of the in vivo situation
by the HepG2-4A5 system. As HepG2-4A5 cells containers that hepatitis B viruses produced in vitro are infectious
in chimpanzees after intravenous inoculation (7 ). As Dane each of the HBV ORFs only once, this system is best fit to
quantify the viral messages. Because of the autologousparticles produced by HepG2-4A5 cells are indistinguish-
able from those found in infectious human sera, it is highly control of all the viral transcripts and the single-inte-
grated HBV genome, HepG2-4A5 cells synthesizelikely that they are also infectious, although their infectivity
has not been proven so far, due to the lack of a common amounts of viral particles that are several-fold lower than
the amounts synthesized by HepG2-2.2.15 cells (Figs. 1cin vitro infection system.
As we know, this is the first stably transfected cell and 2c). Thus, in comparison with the HBV-producing
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